Applications published 19 December 2007

• Diindolylmethane-based compsns and methods of use thereof for promoting oral mucosal and bone health
Bioresponse 1865929*

• Multilayered dosing systems
Advance IP Technologies 1865930*

• Transdermal patch
Bouty 1865931*

• Rechargeable dermal patch
Millet Innovation 1865932*

• Low-concentration capsaicin patch and methods for treating neuropathic pain
Neurogesx 1865933*

• Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device
Canon 1865934*

• Bisphosphonates for treating endometriosis
Hadasit Medical Research Services and Development 1865935*

• Method of regulating mammalian keratinous tissue
Procter & Gamble 1865936*

• Antibacterial 5’,5-disubstituted 3,3’-dialkoxy-2,2’-dihydroxy-1,1’-biphenyl compounds and related methods
Colgate-Palmolive 1865937*

• Dosing regimes for trans-clomiphene
Repros Therapeutics 1865938*

• Metformin methods and formulations for treating chronic constipation
AGI Therapeutics Research 1865939*

• Alpha ketoamide compounds as cysteine protease inhibitors
Applera 1865940*

• Oils of capsaicinoids and methods of making same and using the same
Neurogesx 1865941*

• Novel inhibitors of glutathione-S-transferase
Universität Giessen; Max-Planck-Gesellschaft zur Förderung der Wissenschaften 1865942*

• Use of an ecetyl-leucine for preparing a drug for treating balance disorders
Pierre Fabre Medicament 1865943*

• Amino acid-containing compsn for preventing or remedying in the skeletal muscle of aged people
Ajinomoto 1865944*

• Combination therapy for endothelial dysfunction, angina and diabetes
Hong Kong Nitric Oxide 1865945*

• Method of modulating drug release from a coated substrate
Boston Scientific 1865946*

• The use of ezetimibe in the prevention and treatment of cholesterol gallstones
Pontificia Universidad Catolica de Chile 1865947*

• Vitamin mixtures
Novartis 1865948*

• Modulators of ATP-binding cassette transporters
Vertex Pharmaceuticals 1865949*

• Compounds useful as modulators of the proteasome activity
Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie 1865950*

• Method for preventing cardiovascular diseases
Nycomed 1865951*

• Histamine-containing compsns for the treatment of allergic diseases
Jeon, Sook-Yeuog; Nahm, Dong-Ho 1865952*

• Compsn comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
Yu, Ruey; Van Scott, Eugene 1865953*

• Methods for avoiding oedema in the treatment or prevention of PPAR gamma-responsive diseases, including cancer
Metabolex 1865954*

• Method of treating men with testosterone supplement and 5-alpha-reductase inhibitor
Merck 1865955*

• Piperidinyl substituted cyclohexane-1,4-diamines
Janssen Pharmaceutica 1865956*

• Method of treating actinic keratosis
Meda 1865957*

• Pharmacokinetically improved compounds
Surface Logix; Bartolozzi, Alessandra; Sweetnam, Paul 1865958*

• Process for preparing pyridoyl-2,3-D-pyrimidin-7-one and 3,4-dihydropyrimidoyl-4,5-D-pyrimidin-2(1H)-one derivatives
Glaxo Group 1865959*

• Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
Novartis; Novartis-Pharma 1865960*

• Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
Novartis; Novartis-Pharma 1865961*

• Use of N-desmethylclozapine and related compounds as dopamine stabilising agents
Acadia Pharmaceuticals 1865962*

• Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor
Acadia Pharmaceuticals 1865963*

• Topical formulations for use in the treatment or prevention of dermatological conditions
Stegram Pharmaceuticals 1865964*

• 2-methylene-19-nor-(23S)-25-dehydro-1?-hydroxyvitamine D3-26,23-lactone and 2-methylene-19-nor-(23RT)-25-dehydro-1-hydroxyvitamin D3-26,23-lactone
Wisconsin Alumni Research Foundation 1865965*

• Use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
Medestea Research & Production 1865966*

• Compounds, compsns and methods for the treatment of viral infections and other medical disorders
Chimerix 1865967*

• Topical formulations of borinic acid antibodies and their methods of use
Anacor Pharmaceuticals 1865968*

• Ultra-low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells
The Regents of the University of California 1865969*

• Treatment or prevention of cancer or precancerous disorders
Florida Atlantic University 1865972*

• Novel probiotic
Wageningen Universiteit 1865973*

• Combination consisting of a histological or cytological fixing solution and of one or more photoactivatable compounds of the family of quinones, in particular, hypericin, hypocrellin A and hypercrelling B
Novacyt 1865974*

• Compsns containing cotinus coggyria extract and use thereof on mucosal tissues
Johnson & Johnson Consumer Companies 1865975*

• Use of natriuretic peptide for treating heart failure
Cardiopep Pharma 1865976*

• Methods and compsns for derepression of IAP-inhibited caspase
The Burnham Institute for Medical Research; Torrey Pines Institute for Molecular Studies 1865977*

• New neuronal pain pathway
The Trustees of Columbia University in the City of New York 1865978*

• Treatment of cognitive and learning impairment
Istituto Superiore di Sanita’ 1865979*

• Abuse resistant amphetamine prodrugs
New River Pharmaceuticals 1865980*

• CACNA1E in cancer diagnosis, detection and treatment
Chiron; Sagres Discovery 1865981*

• Hydrogel compsn for modulation of topical inflammatory response
Bioartificial Gel Technologies 1865982*